New biotech Semma Therapeutics joins ViaCyte & Betalogics in stem cell Diabetes arena
A new biotech startup, Semma Therapeutics, announced that it seeks to fight diabetes via translating technology from the lab of Doug Melton at Harvard to the clinic. Another major player in cell therapy-based arena for Diabetes is most likely good news […]